12:43 PM EST - Knight Therapeutics Inc. : Reported financial results for its second quarter ended June 30, 2021. Revenues were a record $65.7 million, an increase of $12.5 million, or 24% over prior year. Net income was $29,004, an increase of $13,492 or 87% over prior year. Knight Therapeutics Inc.
shares T.GUD are trading up $0.52 at $5.66.
